XOMA 052 Clinical Results Support Novel Anti-Inflammatory Approach ... - GlobeNewsWire (press release)

XOMA 052 Clinical Results Support Novel Anti-Inflammatory Approach ... GlobeNewsWire (press release), CA ... rheumatoid arthritis, gout and other diseases. By binding to IL-1 beta, the drug inhibits the activation of the IL-1 receptor, thereby preventing the cellular signaling events that produce inflammation. XOMA 052 has a half-life of 22 days. ...

Why Are Hormone Makers Still Pushing HRT? - NewsBlaze

Why Are Hormone Makers Still Pushing HRT? NewsBlaze, CA Instead of preventing blood clots, it doubles the risk. Hormone therapy also increases the risk of ovarian cancer, dementia, asthma, malignant melanoma, urinary incontinence, gout, the need for joint replacement, gallbladder disease, dying of lung ...

Dual energy CT shows promise as new diagnostic method for gout - MTBeurope

Dual energy CT shows promise as new diagnostic method for gout MTBeurope, UK If we are able to detect the disease in an early stage, we can initiate a treatment to prevent destruction of the tendons and ligaments and joints where subclinical tophi are present." "DECT is a promising new technique that can in a reliable, ...

CORRECT: Savient Up As Investors More Confident In Drug Approval - Wall Street Journal

CORRECT: Savient Up As Investors More Confident In Drug Approval Wall Street Journal "They could prevent people with multiple cardiovascular risk factors from getting it, as well as people who don't respond to it any longer," Schwartz said, adding a similar gout drug developed by Takeda Pharmaceutical Co. (4502.TO) was approved earlier ...